Dr. Hambik H. Tankazyan, DO

Dr. Tankazyan practices at Heartbeat Cardiovascular Medical Group in Glendale, California.

Dr. Tankazyan's NPI, 1720378268, was assigned on April 18, 2011. Dr. Tankazyan graduated from WesternU College of Osteopathic Medicine of the Pacific in 2011. Dr. Tankazyan holds California license 20A12498.

Dr. Tankazyan's primary practice is Heartbeat Cardiovascular Medical Group, at 660 W Broadway, Glendale, CA 91204 in Los Angeles County. The practice phone is (818) 243-9600.

Dr. Tankazyan's primary practice is Heartbeat Cardiovascular Medical Group in Glendale, California. Dr. Tankazyan is also affiliated with USC Verdugo Hills Hospital. The medical group on file is Heartbeat Cardiovascular Medical Group. Dmand AI also links Dr. Tankazyan to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tankazyan practices, 5 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Tankazyan's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Tankazyan is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Tankazyan is licensed in California.

Dmand AI lists aneurysm, angioplasty, atrial fibrillation and flutter, cardiac catheterization, cerebrovascular disease, chronic hypertension, coronary artery disease and heart attack among the conditions Dr. Tankazyan treats.

CMS data shows 6,605 Medicare services from Dr. Tankazyan across 43 procedure codes in 2024, for 1,500 Medicare patients. Medicare paid $319,328 for them.

CMS counts 1,500 Medicare patients who saw Dr. Tankazyan in 2024. The largest group is 65 to 74, with 612 patients. 75% of them have arthritis, and 75% have high blood pressure. 83% are also on Medicaid. Their average risk score is 2.21, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Tankazyan's median patient age at 65, with 45% women.

In 2024, Dr. Tankazyan wrote 5,026 Medicare Part D claims for 533 patients. 73% of them were for generic drugs. CMS names the drug for 4,799 of them, across 60 drugs with 11 or more claims each, at $1,001,926 in total drug cost. In 2023, CMS named 3,565 claims across 52 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Tankazyan for performance year 2024, reported individually. Dr. Tankazyan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 46 procedures of coronary angioplasty and stenting by Dr. Tankazyan, more than 81% of the clinicians it reports for that procedure.

CMS Open Payments shows 677 general payments to Dr. Tankazyan from 30 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 76% of the total. Abbott Laboratories paid the most, $13,404. It also lists 6 research payments totaling $361 in 2023.

Dr. Tankazyan graduated from WesternU College of Osteopathic Medicine of the Pacific in 2011.

Dr. Tankazyan is in network with 12 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.